Norris Medicines informs about board meeting

02 Feb 2018 Evaluate

Under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015, Norris Medicines has informed that a meeting of Board of Directors of the Company will be held on Saturday, 02nd February, 2018, to consider and approve unaudited Financial Results of the Company for the quarter ended 31st December, 2017. Further, the trading window shall remain closed from 02nd February, 2018 to 13th February, 2018.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

13.82 -0.15 (-1.07%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×